CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33,000 enrolled
Drug / intervention
Sugar sweetened beverage (SSB)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03173586
NCT03173586N/ACompleted
CompareCT.gov

Association Between Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women

Harvard School of Public Health (HSPH)·observational·Posted Jun 2, 2017·Updated Jun 2, 2017

In Brief

An observational study evaluating Sugar sweetened beverage (SSB) for Biomarkers. Completed, enrolled 33,000 participants across 1 site.

Detailed Summary

This study is a secondary analysis of data collected in the Nurses' Health Study (NHS) that will evaluat the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages in relation to biomarkers of hepatic function, lipid metabolism, inflammation and glycemic control.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBiomarkers
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2, 2017
Enrollment StartSep 16, 1999
Primary CompletionMar 31, 2009
TodayJul 2, 2026
Enrollment to primary: 9.5 yearsPosted 9.1 years ago

Interventions

Sugar sweetened beverage (SSB)other

This is an observational study examining sugar sweetened beverage intake in relation to biomarkers in the NHS.